on VALBIOTIS (EPA:ALVAL)
Valbiotis awarded the Top Santé 2025 prize for its Valbiotis Plus® Serenity supplement
On December 18, 2025, Valbiotis, a French company specializing in food supplements, was honored with the Top Santé 2025 award for its Valbiotis Plus® Sérénité product. This award, presented at the 6th edition of the competition organized by the media outlet Top Santé, recognizes the most outstanding innovations in 19 health categories. Valbiotis Plus® Sérénité, recognized for its effectiveness and ethical approach, exemplifies the company's scientific commitment.
This award comes at a time of declining mental well-being in France, where 59% of French people report experiencing stress. Valbiotis Plus® Serenity addresses these growing needs by offering a natural and scientifically validated solution. This recognition strengthens Valbiotis' strategic position and increases the visibility of its innovative product range.
R. E.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all VALBIOTIS news